7-143390632-G-T
Variant names:
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PP3_ModerateBS2
The NM_003461.5(ZYX):c.1669G>T(p.Asp557Tyr) variant causes a missense change. The variant allele was found at a frequency of 0.00000557 in 1,435,740 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: not found (cov: 32)
Exomes 𝑓: 0.0000056 ( 0 hom. )
Consequence
ZYX
NM_003461.5 missense
NM_003461.5 missense
Scores
12
5
1
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 6.75
Genes affected
ZYX (HGNC:13200): (zyxin) Focal adhesions are actin-rich structures that enable cells to adhere to the extracellular matrix and at which protein complexes involved in signal transduction assemble. Zyxin is a zinc-binding phosphoprotein that concentrates at focal adhesions and along the actin cytoskeleton. Zyxin has an N-terminal proline-rich domain and three LIM domains in its C-terminal half. The proline-rich domain may interact with SH3 domains of proteins involved in signal transduction pathways while the LIM domains are likely involved in protein-protein binding. Zyxin may function as a messenger in the signal transduction pathway that mediates adhesion-stimulated changes in gene expression and may modulate the cytoskeletal organization of actin bundles. Alternative splicing results in multiple transcript variants that encode the same isoform. [provided by RefSeq, Jul 2008]
EPHA1 (HGNC:3385): (EPH receptor A1) This gene belongs to the ephrin receptor subfamily of the protein-tyrosine kinase family. EPH and EPH-related receptors have been implicated in mediating developmental events, particularly in the nervous system. Receptors in the EPH subfamily typically have a single kinase domain and an extracellular region containing a Cys-rich domain and 2 fibronectin type III repeats. The ephrin receptors are divided into 2 groups based on the similarity of their extracellular domain sequences and their affinities for binding ephrin-A and ephrin-B ligands. This gene is expressed in some human cancer cell lines and has been implicated in carcinogenesis. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -2 ACMG points.
PP3
MetaRNN computational evidence supports a deleterious effect, 0.886
BS2
High AC in GnomAdExome4 at 8 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ZYX | NM_003461.5 | c.1669G>T | p.Asp557Tyr | missense_variant | Exon 10 of 10 | ENST00000322764.10 | NP_003452.1 | |
ZYX | NM_001010972.2 | c.1669G>T | p.Asp557Tyr | missense_variant | Exon 10 of 10 | NP_001010972.1 | ||
ZYX | NM_001362783.2 | c.1576G>T | p.Asp526Tyr | missense_variant | Exon 9 of 9 | NP_001349712.1 | ||
ZYX | XM_047420817.1 | c.1576G>T | p.Asp526Tyr | missense_variant | Exon 9 of 9 | XP_047276773.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZYX | ENST00000322764.10 | c.1669G>T | p.Asp557Tyr | missense_variant | Exon 10 of 10 | 1 | NM_003461.5 | ENSP00000324422.5 | ||
ZYX | ENST00000354434.8 | c.1573G>T | p.Asp525Tyr | missense_variant | Exon 8 of 8 | 2 | ENSP00000346417.4 | |||
ZYX | ENST00000392910.6 | c.1198G>T | p.Asp400Tyr | missense_variant | Exon 9 of 9 | 2 | ENSP00000376642.2 | |||
EPHA1 | ENST00000458129.1 | n.308C>A | non_coding_transcript_exon_variant | Exon 2 of 2 | 3 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD3 exomes AF: 0.00000476 AC: 1AN: 210132Hom.: 0 AF XY: 0.00000891 AC XY: 1AN XY: 112270
GnomAD3 exomes
AF:
AC:
1
AN:
210132
Hom.:
AF XY:
AC XY:
1
AN XY:
112270
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000557 AC: 8AN: 1435740Hom.: 0 Cov.: 30 AF XY: 0.00000843 AC XY: 6AN XY: 711448
GnomAD4 exome
AF:
AC:
8
AN:
1435740
Hom.:
Cov.:
30
AF XY:
AC XY:
6
AN XY:
711448
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Uncertain
D;D;.
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Pathogenic
D
M_CAP
Uncertain
D
MetaRNN
Pathogenic
D;D;D
MetaSVM
Pathogenic
D
MutationAssessor
Pathogenic
M;.;.
PrimateAI
Uncertain
T
PROVEAN
Pathogenic
D;D;D
REVEL
Pathogenic
Sift
Uncertain
D;D;D
Sift4G
Pathogenic
D;D;D
Polyphen
D;.;.
Vest4
MutPred
Loss of solvent accessibility (P = 0.0152);.;.;
MVP
MPC
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at